Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001209191-21-043738

President and CEO sold 204 shares at $35.53 ($7,248)

  • President and CEO acquired 204 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mack David Henry President and CEO 2021-06-28 Option exercise +204 $0.53 $108 12,674 D: show line 1 in the form
Mack David Henry President and CEO 2021-06-28 Sale −204 $35.53 $7,248 12,470 D: show line 2 in the form
Open-market sales · 204 sh · avg $35.53 · $7,248

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Mack David Henry President and CEO 2021-06-28 Option exercise · Stock Option (right to buy) −204 474,870 D: show line 3 in the form
Loading xslF345X03/doc4.xml…